Annual CFF
-$121.00 K
-$20.09 M-100.61%
31 December 2023
Summary:
Candel Therapeutics annual cash flow from financing activities is currently -$121.00 thousand, with the most recent change of -$20.09 million (-100.61%) on 31 December 2023. During the last 3 years, it has fallen by -$611.00 thousand (-124.69%). CADL annual CFF is now -100.17% below its all-time high of $71.80 million, reached on 31 December 2021.CADL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.68 M
-$268.00 K-13.78%
30 September 2024
Summary:
Candel Therapeutics quarterly cash flow from financing activities is currently $1.68 million, with the most recent change of -$268.00 thousand (-13.78%) on 30 September 2024. Over the past year, it has increased by +$1.68 million (+100.00%). CADL quarterly CFF is now -97.65% below its all-time high of $71.36 million, reached on 30 September 2021.CADL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.25 M
+$1.68 M+294.73%
30 September 2024
Summary:
Candel Therapeutics TTM cash flow from financing activities is currently $2.25 million, with the most recent change of +$1.68 million (+294.73%) on 30 September 2024. Over the past year, it has increased by +$2.21 million (+6138.89%). CADL TTM CFF is now -97.55% below its all-time high of $91.60 million, reached on 31 March 2022.CADL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CADL Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.6% | +100.0% | +6138.9% |
| 3 y3 years | -124.7% | -97.7% | -96.9% |
| 5 y5 years | - | - | - |
CADL Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.2% | at low | -97.7% | +233.6% | -97.5% | +263.2% |
| 5 y | 5 years | -100.2% | at low | -97.7% | +233.6% | -97.5% | +263.2% |
| alltime | all time | -100.2% | at low | -97.7% | +233.6% | -97.5% | +263.2% |
Candel Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.68 M(-13.8%) | $2.25 M(+294.7%) |
| June 2024 | - | $1.95 M(-255.0%) | $569.00 K(-141.4%) |
| Mar 2024 | - | -$1.25 M(+937.2%) | -$1.38 M(+1037.2%) |
| Dec 2023 | -$121.00 K(-100.6%) | -$121.00 K(<-9900.0%) | -$121.00 K(-436.1%) |
| Sept 2023 | - | $0.00(0.0%) | $36.00 K(0.0%) |
| June 2023 | - | $0.00(0.0%) | $36.00 K(-37.9%) |
| Mar 2023 | - | $0.00(-100.0%) | $58.00 K(-99.7%) |
| Dec 2022 | $19.97 M | $36.00 K(>+9900.0%) | $19.97 M(+0.2%) |
| Sept 2022 | - | $0.00(-100.0%) | $19.94 M(-78.2%) |
| June 2022 | - | $22.00 K(-99.9%) | $91.29 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $19.92 M(>+9900.0%) | $91.60 M(+27.6%) |
| Dec 2021 | $71.80 M(>+9900.0%) | $0.00(-100.0%) | $71.80 M(-0.0%) |
| Sept 2021 | - | $71.36 M(>+9900.0%) | $71.83 M(>+9900.0%) |
| June 2021 | - | $333.00 K(+197.3%) | $474.00 K(-21.1%) |
| Mar 2021 | - | $112.00 K(+286.2%) | $601.00 K(+22.7%) |
| Dec 2020 | $490.00 K(-97.8%) | $29.00 K(>+9900.0%) | $490.00 K(+6.3%) |
| Sept 2020 | - | $0.00(-100.0%) | $461.00 K(0.0%) |
| June 2020 | - | $460.00 K(>+9900.0%) | $461.00 K(>+9900.0%) |
| Mar 2020 | - | $1000.00 | $1000.00 |
| Dec 2019 | $21.98 M | - | - |
FAQ
- What is Candel Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Candel Therapeutics?
- What is Candel Therapeutics annual CFF year-on-year change?
- What is Candel Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Candel Therapeutics?
- What is Candel Therapeutics quarterly CFF year-on-year change?
- What is Candel Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Candel Therapeutics?
- What is Candel Therapeutics TTM CFF year-on-year change?
What is Candel Therapeutics annual cash flow from financing activities?
The current annual CFF of CADL is -$121.00 K
What is the all time high annual CFF for Candel Therapeutics?
Candel Therapeutics all-time high annual cash flow from financing activities is $71.80 M
What is Candel Therapeutics annual CFF year-on-year change?
Over the past year, CADL annual cash flow from financing activities has changed by -$20.09 M (-100.61%)
What is Candel Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CADL is $1.68 M
What is the all time high quarterly CFF for Candel Therapeutics?
Candel Therapeutics all-time high quarterly cash flow from financing activities is $71.36 M
What is Candel Therapeutics quarterly CFF year-on-year change?
Over the past year, CADL quarterly cash flow from financing activities has changed by +$1.68 M (+100.00%)
What is Candel Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CADL is $2.25 M
What is the all time high TTM CFF for Candel Therapeutics?
Candel Therapeutics all-time high TTM cash flow from financing activities is $91.60 M
What is Candel Therapeutics TTM CFF year-on-year change?
Over the past year, CADL TTM cash flow from financing activities has changed by +$2.21 M (+6138.89%)